Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
25M
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
1.23M
-
Shares change
-
+1.21M
-
Total reported value, excl. options
-
$4.25M
-
Value change
-
+$4.19M
-
Number of buys
-
15
-
Number of sells
-
-4
-
Price
-
$3.46
Significant Holders of TENAX THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (TENX) as of Q3 2024
22 filings reported holding TENX - TENAX THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q3 2024.
TENAX THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (TENX) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.23M shares
of 25M outstanding shares and own 4.93% of the company stock.
Largest 10 shareholders include BVF INC/IL (340K shares), VR Adviser, LLC (208K shares), Vivo Capital, LLC (208K shares), Vestal Point Capital, LP (83.3K shares), Velan Capital Investment Management LP (83.3K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (83.3K shares), ADAR1 Capital Management, LLC (62.4K shares), Stonepine Capital Management, LLC (50K shares), SPHERA FUNDS MANAGEMENT LTD. (29.2K shares), and PRICE T ROWE ASSOCIATES INC /MD/ (24K shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.